FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2796009216> ?p ?o ?g. }

• W2796009216 endingPage "345" @default.
• W2796009216 startingPage "341" @default.
• W2796009216 abstract "Objective Experimental inflammation induces degradation of glycocalyx. The authors hypothesized that inflammation is an important determinant of glycocalyx degradation in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Design A prospective observational study. Setting Operation theater and intensive care unit of a university hospital. Participants Two separate prospective patient cohorts. Interventions Blood samples were collected at 5 perioperative time points in the trial cohort (30 patients) and only preoperatively in the preoperative cohort (35 patients). Plasma syndecan-1 (biomarker of glycocalyx degradation), interleukin-6 (IL-6), IL-8, and IL-10 were measured. Measurements and Main Results In the trial cohort, preoperative ranges were as follows: 0.8-198 ng/mL for syndecan-1; 0-902 pg/mL for IL-6; 0-314.9 pg/mL for IL-8, and 0-2,909 pg/mL for IL-10. Seven out of 30 patients were outliers in terms of plasma concentrations of syndecan-1 and all cytokines preoperatively. The increase of syndecan-1 was 2.7-fold, and those of IL-6 and IL-8 were both 2.5-fold. The increase of IL-10 was modest. Plasma syndecan-1 correlated with all cytokines preoperatively (IL-6: R = 0.66, p < 0.001; IL-8: R = 0.67, p = 0.001; IL-10: R = 0.73, p < 0.001) as well as at 6 hours postoperatively (IL-6: R = 0.49, p = 0.006; IL-8: R = 0.43, p = 0.02; IL-10: R = 0.41, p = 0.03) and on the postoperative morning (IL-6: R = 0.57, p = 0.001; IL-8: R = 0.37, p = 0.06; IL-10: R = 0.51, p = 0.005) but not intraoperatively. The preoperative findings of the trial cohort could be confirmed in the preoperative cohort. Conclusions In patients undergoing cardiac surgery with CPB, inflammation in terms of proinflammatory cytokines IL-6 and IL-8 and anti-inflammatory cytokine IL-10 is associated with glycocalyx degradation measured as plasma syndecan-1 concentrations. Experimental inflammation induces degradation of glycocalyx. The authors hypothesized that inflammation is an important determinant of glycocalyx degradation in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). A prospective observational study. Operation theater and intensive care unit of a university hospital. Two separate prospective patient cohorts. Blood samples were collected at 5 perioperative time points in the trial cohort (30 patients) and only preoperatively in the preoperative cohort (35 patients). Plasma syndecan-1 (biomarker of glycocalyx degradation), interleukin-6 (IL-6), IL-8, and IL-10 were measured. In the trial cohort, preoperative ranges were as follows: 0.8-198 ng/mL for syndecan-1; 0-902 pg/mL for IL-6; 0-314.9 pg/mL for IL-8, and 0-2,909 pg/mL for IL-10. Seven out of 30 patients were outliers in terms of plasma concentrations of syndecan-1 and all cytokines preoperatively. The increase of syndecan-1 was 2.7-fold, and those of IL-6 and IL-8 were both 2.5-fold. The increase of IL-10 was modest. Plasma syndecan-1 correlated with all cytokines preoperatively (IL-6: R = 0.66, p < 0.001; IL-8: R = 0.67, p = 0.001; IL-10: R = 0.73, p < 0.001) as well as at 6 hours postoperatively (IL-6: R = 0.49, p = 0.006; IL-8: R = 0.43, p = 0.02; IL-10: R = 0.41, p = 0.03) and on the postoperative morning (IL-6: R = 0.57, p = 0.001; IL-8: R = 0.37, p = 0.06; IL-10: R = 0.51, p = 0.005) but not intraoperatively. The preoperative findings of the trial cohort could be confirmed in the preoperative cohort. In patients undergoing cardiac surgery with CPB, inflammation in terms of proinflammatory cytokines IL-6 and IL-8 and anti-inflammatory cytokine IL-10 is associated with glycocalyx degradation measured as plasma syndecan-1 concentrations." @default.
• W2796009216 created "2018-04-13" @default.
• W2796009216 creator A5007040861 @default.
• W2796009216 creator A5007865127 @default.
• W2796009216 creator A5016579653 @default.
• W2796009216 creator A5049688713 @default.
• W2796009216 creator A5055770780 @default.
• W2796009216 creator A5056575891 @default.
• W2796009216 creator A5056646848 @default.
• W2796009216 creator A5069808930 @default.
• W2796009216 date "2019-02-01" @default.
• W2796009216 modified "2023-09-30" @default.
• W2796009216 title "Glycocalyx Degradation and Inflammation in Cardiac Surgery" @default.
• W2796009216 cites W1970714964 @default.
• W2796009216 cites W1973654637 @default.
• W2796009216 cites W2017295052 @default.
• W2796009216 cites W2017613603 @default.
• W2796009216 cites W2032464831 @default.
• W2796009216 cites W2040242558 @default.
• W2796009216 cites W2048470272 @default.
• W2796009216 cites W2053723007 @default.
• W2796009216 cites W2063500559 @default.
• W2796009216 cites W2065350174 @default.
• W2796009216 cites W2069829981 @default.
• W2796009216 cites W2080171075 @default.
• W2796009216 cites W2097333982 @default.
• W2796009216 cites W2111247242 @default.
• W2796009216 cites W2115000187 @default.
• W2796009216 cites W2120056578 @default.
• W2796009216 cites W2126823517 @default.
• W2796009216 cites W2133930237 @default.
• W2796009216 cites W2149681511 @default.
• W2796009216 cites W2153870838 @default.
• W2796009216 cites W2340810468 @default.
• W2796009216 cites W2510169643 @default.
• W2796009216 doi "https://doi.org/10.1053/j.jvca.2018.04.007" @default.
• W2796009216 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29724540" @default.
• W2796009216 hasPublicationYear "2019" @default.
• W2796009216 type Work @default.
• W2796009216 sameAs 2796009216 @default.
• W2796009216 citedByCount "25" @default.
• W2796009216 countsByYear W27960092162019 @default.
• W2796009216 countsByYear W27960092162020 @default.
• W2796009216 countsByYear W27960092162021 @default.
• W2796009216 countsByYear W27960092162022 @default.
• W2796009216 countsByYear W27960092162023 @default.
• W2796009216 crossrefType "journal-article" @default.
• W2796009216 hasAuthorship W2796009216A5007040861 @default.
• W2796009216 hasAuthorship W2796009216A5007865127 @default.
• W2796009216 hasAuthorship W2796009216A5016579653 @default.
• W2796009216 hasAuthorship W2796009216A5049688713 @default.
• W2796009216 hasAuthorship W2796009216A5055770780 @default.
• W2796009216 hasAuthorship W2796009216A5056575891 @default.
• W2796009216 hasAuthorship W2796009216A5056646848 @default.
• W2796009216 hasAuthorship W2796009216A5069808930 @default.
• W2796009216 hasBestOaLocation W27960092162 @default.
• W2796009216 hasConcept C126322002 @default.
• W2796009216 hasConcept C141071460 @default.
• W2796009216 hasConcept C164705383 @default.
• W2796009216 hasConcept C185592680 @default.
• W2796009216 hasConcept C188816634 @default.
• W2796009216 hasConcept C203014093 @default.
• W2796009216 hasConcept C2776914184 @default.
• W2796009216 hasConcept C2778789114 @default.
• W2796009216 hasConcept C2778881276 @default.
• W2796009216 hasConcept C2780098789 @default.
• W2796009216 hasConcept C2781197716 @default.
• W2796009216 hasConcept C31174226 @default.
• W2796009216 hasConcept C42219234 @default.
• W2796009216 hasConcept C55493867 @default.
• W2796009216 hasConcept C71924100 @default.
• W2796009216 hasConcept C72563966 @default.
• W2796009216 hasConcept C90924648 @default.
• W2796009216 hasConceptScore W2796009216C126322002 @default.
• W2796009216 hasConceptScore W2796009216C141071460 @default.
• W2796009216 hasConceptScore W2796009216C164705383 @default.
• W2796009216 hasConceptScore W2796009216C185592680 @default.
• W2796009216 hasConceptScore W2796009216C188816634 @default.
• W2796009216 hasConceptScore W2796009216C203014093 @default.
• W2796009216 hasConceptScore W2796009216C2776914184 @default.
• W2796009216 hasConceptScore W2796009216C2778789114 @default.
• W2796009216 hasConceptScore W2796009216C2778881276 @default.
• W2796009216 hasConceptScore W2796009216C2780098789 @default.
• W2796009216 hasConceptScore W2796009216C2781197716 @default.
• W2796009216 hasConceptScore W2796009216C31174226 @default.
• W2796009216 hasConceptScore W2796009216C42219234 @default.
• W2796009216 hasConceptScore W2796009216C55493867 @default.
• W2796009216 hasConceptScore W2796009216C71924100 @default.
• W2796009216 hasConceptScore W2796009216C72563966 @default.
• W2796009216 hasConceptScore W2796009216C90924648 @default.
• W2796009216 hasIssue "2" @default.
• W2796009216 hasLocation W27960092161 @default.
• W2796009216 hasLocation W27960092162 @default.
• W2796009216 hasLocation W27960092163 @default.
• W2796009216 hasOpenAccess W2796009216 @default.
• W2796009216 hasPrimaryLocation W27960092161 @default.
• W2796009216 hasRelatedWork W1545120089 @default.
• W2796009216 hasRelatedWork W2000096371 @default.

• next